Opinion
Video
The panelists provide their final takeaways from the discussion surrounding treatment of MDS.
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Navigating Compounded Semaglutide: What Health Care Providers Need to Know
High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management
BMI Screening Overlooks Excess Adiposity in Children Without Obesity
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
Key Risk Factors Uncovered for AD Recurrence After Dupilumab Discontinuation
Economic Burden Is Greater Among Patients With Ovarian Cancer Receiving BRCA Testing